Dexketoprofen/tramadol 25 mg/75 mg: randomised double-blind trial in moderate-to-severe acute pain after abdominal hysterectomy

Table 2 Analysis populations and patient disposition

N	DKP/TRAM			DKP			TRAM			Overall
N	SDP placebo	SDP active	All	SDP placebo	SDP active	All	SDP placebo	SDP active	All	Overall
ITT population	51	152	203	51	151	202	51	150	201	606
Safety population	52	151	203	50	152	202	51	150	201	606
PP population	43	127	170	42	129	171	40	124	164	505

N number of patients, DKP/TRAM dexketoprofen trometamol/tramadol hydrochloride 25 mg/75 mg, DKP dexketoprofen trometamol 25 mg, TRAM tramadol hydrochloride 100 mg, SDP single-dose phase, ITT intention-to-treat, PP per protocol. The ITT population included all patients randomised; the safety population included all patients randomised who received at least one dose of study treatment; the PP population included all ITT patients with no major protocol violations

ISSN: 1471-2253